12/09/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
4:02 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:03 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:05 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
4:09 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/06/2024
4:12 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:38 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:39 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:39 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:06 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:07 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:08 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:31 AM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
9:42 AM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
5:29 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:40 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:42 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
4:07 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
4:33 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:31 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:32 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:32 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:37 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
4:14 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
7:22 PM | Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:24 PM | Anthony Todd M. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:25 PM | Bitterman Chris T. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:26 PM | Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:28 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:29 PM | Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:31 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:31 PM | Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:32 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:33 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 424B5 | |
03/20/2024
4:20 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:03 PM | Cumberland Pharmaceuticals (Filer)
| Form DEF 14A | |
03/13/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form DEFA14A | |
Kamala’s final humiliation (Ad) The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware of… yet have the potential to deliver colossal returns over the next four years.
I’m not talking about Tesla, Palantir, or anything else you’ve heard parroted by the mainstream financial press. No. These are Trump’s Secret Stocks.  It’s all waiting for you here. |
03/05/2024
4:10 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
4:27 PM | Cumberland Pharmaceuticals (Subject)
| Form SC 13G | |
